Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (30)

Company Market Cap Price
KVUE Kenvue Inc.
Band-Aid wound care devices fall under Kenvue's wound care product category.
$27.59B
$14.37
+0.91%
SOLV Solventum Corporation
V.A.C. Peel and Place dressing is a wound care device, a core MedSurg product.
$11.94B
$69.04
-0.35%
BAX Baxter International Inc.
Wound Care Devices are a distinct medical device category Baxter markets.
$9.48B
$18.46
-3.63%
TFX Teleflex Incorporated
QuikClot Control+ hemostatic devices expand Teleflex's wound care and bleeding-control product line.
$5.50B
$124.49
-0.28%
VCEL Vericel Corporation
NexoBrid and burn/wound care products place Vericel in the wound care products category.
$1.77B
$35.05
+1.51%
UFPT UFP Technologies, Inc.
Wound care devices are highlighted as a notable medical segment in UFPT's growth.
$1.48B
$192.64
+3.97%
MDXG MiMedx Group, Inc.
Directly manufactures and sells wound care devices and placental tissue allografts (EPIFIX, EPICORD, EPIEFFECT) used in wound healing.
$1.13B
$7.64
+3.24%
AXGN AxoGen, Inc.
The Avance Nerve Graft and tissue matrices support tissue healing and nerve injury repair, aligning with Wound Care Devices.
$1.02B
$22.22
-2.03%
IART Integra LifeSciences Holdings Corporation
Wound care/regenerative product portfolio (IDRT, PriMatrix, SurgiMend, DuraSorb, MediHoney) constitutes major product lines.
$935.71M
$12.02
+1.78%
ORGO Organogenesis Holdings Inc.
Core wound care device category covering Apligraf and Dermagraft, along with barrier products like PuraPly and FortiShield.
$539.13M
$4.25
+0.59%
SMTI Sanara MedTech Inc.
core wound care devices include CellerateRX Surgical Activated Collagen and BIASURGE antimicrobial wound care products.
$260.41M
$29.23
+1.46%
SNWV SANUWAVE Health, Inc.
Core product is a noninvasive wound care device (UltraMIST) used in wound healing.
$247.60M
$29.08
+3.78%
INFU InfuSystem Holdings, Inc.
Advanced wound care devices are a key growth area via its wound care partnerships.
$217.30M
$10.38
+3.80%
MDWD MediWound Ltd.
Products focus on wound care and debridement, which maps to the Wound Care Devices category.
$192.67M
$18.33
-1.19%
AVHHL AVITA Medical, Inc.
AVITA Medical’s core offerings are wound care devices and dermal matrices (RECELL system, RECELL GO, PermeaDerm, Cohealyx) used in wound management, fitting the Wound Care Devices category.
$150.63M
$1.11
ACU Acme United Corporation
Wound care devices are part of the medical product line associated with first aid.
$144.08M
$38.16
-0.42%
XTNT Xtant Medical Holdings, Inc.
Adjacent wound care device opportunities within the OEM/biologics offering.
$122.53M
$0.87
-4.90%
RCEL AVITA Medical, Inc.
RECELL System and Cohealyx/PermeaDerm are wound care devices used for wound closure and healing.
$102.30M
$3.85
+4.90%
MDAI Spectral AI, Inc.
DeepView targets wound care diagnostics and treatment decision support, aligning with Wound Care Devices.
$54.84M
$2.12
+1.19%
CELU Celularity Inc.
Biovance, Interfyl and other biomaterials relate to wound care devices with 510k activity.
$46.70M
$1.94
+2.38%
ELUT Elutia Inc.
Wound care device category appropriate given the biomatrix’s role in healing and tissue integration around implants.
$37.39M
$0.90
-0.69%
CLGN CollPlant Biotechnologies Ltd.
VergenixSTR is a soft tissue repair device, a form of wound/soft tissue regeneration device.
$24.74M
$2.20
+0.46%
NXGL NEXGEL, Inc.
Hydrogel-based wound care device applications are highlighted as medical uses for NXGEL's technology.
$18.83M
$2.46
-1.41%
CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
MEDIFLY maggot debridement therapy is Cuprina's flagship wound care device/product.
$17.61M
$0.97
+10.39%
UEEC United Health Products, Inc.
CelluSTAT functions as a wound care device designed to stop bleeding and support healing.
$14.18M
$0.06
NBY NovaBay Pharmaceuticals, Inc.
Directly manufactures wound care devices which are the sole continuing reportable product line (export to China).
$6.69M
$1.16
-2.12%
SNOA Sonoma Pharmaceuticals, Inc.
Company offers HOCl-based wound care products that function as wound care solutions/devices.
$6.47M
$3.92
-0.76%
VTAK Catheter Precision, Inc.
LockeT is a wound care device, placing it in Wound Care Devices.
$1.42M
$2.45
+2.08%
NAOV NanoVibronix, Inc.
Legacy products include wound care devices (UroShield, PainShield), placing the company in the wound care devices category.
$1.33M
$5.09
-4.14%
AURX Nuo Therapeutics, Inc.
Aurix System is a wound care device used for chronic wounds (direct product).
$972618
$2.00

Loading company comparison...

Loading research report...

IART Integra LifeSciences Holdings Corporation

Integra LifeSciences Reports Q3 2025 Earnings, Beats Adjusted EPS but Misses Revenue Forecast

Oct 30, 2025
MDAI Spectral AI, Inc.

Spectral AI Raises $7.6 Million in Additional Growth Capital

Oct 23, 2025
SNOA Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals Registers Manufacturing Facility and Facial Spray Under FDA MoCRA

Oct 07, 2025
MDXG MiMedx Group, Inc.

MiMedx Group Launches EPIXPRESS® – New Fenestrated Placental Allograft for Acute and Chronic Wounds

Oct 06, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Announces Second Phase 3 ReNu Study Did Not Meet Primary Endpoint Statistical Significance

Sep 25, 2025
MDAI Spectral AI, Inc.

Spectral AI Named to TIME's World's Top HealthTech Companies 2025 List

Sep 19, 2025
MDAI Spectral AI, Inc.

DeepView System Featured Prominently at European Burns Association Congress

Sep 10, 2025
MDAI Spectral AI, Inc.

Spectral AI Reports Q2 2025 Financial Results Amid Strategic Advances

Aug 12, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Reports Second Quarter 2025 Financial Results Amidst Market Disruption

Aug 07, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy for 2026

Jul 15, 2025
MDAI Spectral AI, Inc.

Spectral AI Submits DeepView System De Novo Application to FDA

Jun 30, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Removed from Multiple Russell and S&P Indices

Jun 30, 2025
MDAI Spectral AI, Inc.

DeepView System Showcased at British Burn Association Conference with Positive Clinical Feedback

Jun 10, 2025
MDAI Spectral AI, Inc.

Spectral AI Appoints Stanley Micek as Chief Operating Officer

May 30, 2025
MDAI Spectral AI, Inc.

DeepView System Achieves 95.3% Accuracy in Burns Journal Publication

May 27, 2025
MDAI Spectral AI, Inc.

Spectral AI Research Partner Wins Award for DeepView System Use in Diabetic Foot Ulcer Research

May 20, 2025
MDAI Spectral AI, Inc.

Spectral AI Reports Q1 2025 Net Income of $2.9 Million, Strong Cash Position

May 13, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Reports First Quarter 2025 Financial Results with Revenue Decline and Increased Losses

May 08, 2025
ORGO Organogenesis Holdings Inc.

Global Burn Care Market Projected to Reach $3.35 Billion by 2030, Biologics Segment to Lead Growth

May 02, 2025
MDAI Spectral AI, Inc.

DeepView System's High Accuracy Highlighted at American Burn Association Meeting

Apr 30, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Supports CMS Decision to Delay Local Coverage Determination Implementation

Apr 11, 2025
MDAI Spectral AI, Inc.

Spectral AI Reports Record $29.6 Million Revenue for Full Year 2024, Exceeding Guidance

Mar 27, 2025
MDAI Spectral AI, Inc.

Spectral AI Secures Up to $15 Million Debt Financing and $2.7 Million Equity for U.S. Commercialization

Mar 24, 2025
MDAI Spectral AI, Inc.

Spectral AI Subsidiary Spectral IP Files for Initial Public Offering

Mar 20, 2025
MDAI Spectral AI, Inc.

Spectral AI DeepView System Outperforms Clinical Judgment in Burn Validation Study

Mar 17, 2025
MDAI Spectral AI, Inc.

Spectral AI Installs Three DeepView Systems in Australian Hospitals

Mar 06, 2025
ORGO Organogenesis Holdings Inc.

Organogenesis Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025
MDAI Spectral AI, Inc.

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study with Strong Results

Feb 07, 2025
MDAI Spectral AI, Inc.

Spectral AI Completes Pediatric Enrollment for U.S. Burn Pivotal Study in Emergency Departments

Jan 28, 2025
MDAI Spectral AI, Inc.

Spectral AI Anticipates Exceeding 2024 Revenue Guidance with Record Performance

Jan 22, 2025
MDAI Spectral AI, Inc.

Spectral AI Confirms Nasdaq Listing Compliance

Dec 23, 2024
MDAI Spectral AI, Inc.

Spectral AI Believes It Has Regained Nasdaq Minimum Market Value Compliance

Dec 13, 2024
MDAI Spectral AI, Inc.

Spectral AI Enhances DeepView Software with Frontline Feedback for UK and Australian Deployments

Dec 09, 2024
MDAI Spectral AI, Inc.

Spectral AI Completes Burn Center Image Truthing, Expands to Emergency Departments

Dec 02, 2024
MDAI Spectral AI, Inc.

Spectral AI Reprices Public Warrants to $2.75 Per Share

Nov 26, 2024
ORGO Organogenesis Holdings Inc.

Organogenesis Expands Manufacturing Capacity with New Biomanufacturing Facility in Rhode Island

Nov 22, 2024
MDAI Spectral AI, Inc.

Spectral AI Secures $5 Million Equity Financing, Retires Yorkville Obligations

Nov 19, 2024
ORGO Organogenesis Holdings Inc.

Organogenesis Commends CMS Finalization of Local Coverage Determinations for Skin Substitutes

Nov 15, 2024
ORGO Organogenesis Holdings Inc.

Organogenesis Reports Strong Third Quarter 2024 Financial Results and Raises Full-Year Guidance

Nov 12, 2024
ORGO Organogenesis Holdings Inc.

Organogenesis Reports Favorable Interim Analysis for Second Phase 3 ReNu Clinical Trial in Knee Osteoarthritis

Nov 11, 2024
MDAI Spectral AI, Inc.

Spectral AI Reports Strong Q3 2024 Results, Announces Plan to Spin Off Spectral IP Subsidiary

Nov 06, 2024
MDAI Spectral AI, Inc.

Spectral AI Completes Patient Visits in U.S. Burn Pivotal Study

Oct 30, 2024
MDAI Spectral AI, Inc.

Spectral AI Files for Common Stock Offering

Oct 16, 2024
MDAI Spectral AI, Inc.

Spectral AI Appoints Founder Dr. J. Michael DiMaio as Chairman, CEO Peter Carlson Departs

Oct 14, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks